Euroapi SA, a prominent player in the health care sector, is headquartered in Paris, France. The company is renowned for its specialization in the development, production, and marketing of active pharmaceutical ingredients (APIs). Euroapi’s diverse product portfolio encompasses vitamin B12, prostaglandins, anti-infectives, and both small and complex molecules, catering to a global clientele.
As of November 6, 2025, Euroapi’s close price stood at 3.144 EUR, reflecting a fluctuation within the year. The company’s stock has experienced a 52-week high of 4.46 EUR on December 8, 2024, and a 52-week low of 2.26 EUR on April 6, 2025. These figures highlight the volatility in the company’s stock performance over the past year.
Euroapi SA is listed on the NYSE Euronext Paris, with a market capitalization of 299,770,000 EUR. Despite its significant market presence, the company’s price-to-earnings ratio is currently at -2.39, indicating challenges in profitability or potential losses.
The company’s strategic focus on a wide range of APIs allows it to serve a broad spectrum of pharmaceutical needs. Euroapi’s commitment to innovation and quality is evident in its extensive product offerings, which are distributed globally through its online platform at www.euroapi.com .
In addition to its listing on the NYSE Euronext Paris, Euroapi is also traded on the Frankfurt Stock Exchange, enhancing its visibility and accessibility to international investors. This dual listing underscores the company’s strategic positioning within the European financial markets.
Euroapi’s operations are integral to the health care sector, providing essential components for various pharmaceutical products. The company’s ability to adapt to market demands and its focus on high-quality production processes are key factors in its sustained relevance in the industry.
As Euroapi continues to expand its global reach, it remains committed to maintaining its reputation for excellence in the pharmaceutical industry. The company’s strategic initiatives and product innovations are likely to play a crucial role in its future growth and market performance.
